US-based EnteroMedics' CE Mark for the Maestro Rechargeable (RC) system for obesity has been expanded to include the management of type 2 diabetes mellitus through improved glycemic control.
29 September 2014
2 July 2014
US-based Medtronic has reported results of the OpT2mise trial, which demonstrated that MiniMed insulin pumps safely achieve better glucose control for people with insulin-requiring type 2 diabetes than multiple daily...
16 June 2014
French drug maker Sanofi and Medtronic have signed a memorandum of understanding to enter into a global strategic alliance in diabetes, aimed at improving patient experience and outcomes for sufferers...
30 October 2012
The US Food and Drug Administration (FDA) has granted full approval to GI Dynamics to initiate its ENDO trial, designed to assess the safety and efficacy of EndoBarrier liner in...